Gilenya (fingolimod) - Risk Of Congenital Malformations

GILENYA Recall Summary Gilenya (fingolimod) is being recalled in Canada due to a risk of birth defects if used during pregnancy. The medication is distributed across Canada and is used to treat multiple sclerosis. Women of childbearing age taking this drug should be aware of this safety concern.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2019-12-19

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/6ba6efd5-bb4a-414c-a6ee-8c777afa160e